Report cover image

Opioid Induced Constipation Treatment Market

Publisher Transparency Market Research Pvt. Ltd.
Published Jan 13, 2026
Length 490 Pages
SKU # TNPR20854721

Description

Opioid Induced Constipation Treatment Market – Scope of Report

TMR’s report on the global Opioid Induced Constipation Treatment Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Opioid Induced Constipation Treatment Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Opioid Induced Constipation Treatment Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Global Opioid Induced Constipation Treatment Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Global Opioid Induced Constipation Treatment Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Global Opioid Induced Constipation Treatment Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the Global Opioid Induced Constipation Treatment Market .

The report delves into the competitive landscape of the Global Opioid Induced Constipation Treatment Market. Key players operating in the global Opioid Induced Constipation Treatment Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Opioid Induced Constipation Treatment Market profiled in this report.

Key Questions Answered in Global Opioid Induced Constipation Treatment Market Report
  • What is the sales/revenue generated by Opioid Induced Constipation Treatment Market across all regions during the forecast period?
  • What are the opportunities in the global Opioid Induced Constipation Treatment Market?
  • What are the major drivers, restraints, opportunities, and threats in the Market?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market?
Global Opioid Induced Constipation Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global Opioid Induced Constipation Treatment Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Opioid Induced Constipation Treatment Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market Share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the Opioid Induced Constipation Treatment Market.

Please Note: Report will be updated with the latest data and delivered to you within 2-3 business days.

Table of Contents

490 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Opioid Induced Constipation Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Opioid Induced Constipation Treatment Market Analysis and Forecast, 2021-2036
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Healthcare Expenditure across Key Countries / Regions
5.2. Recent Advancements in Opioid Induced Constipation Treatment
5.3. Pricing Trends for Opioid Induced Constipation Treatment
5.4. Regulatory Scenario across Key Regions / Countries
5.5. PORTER’s Five Forces Analysis
5.6. PESTLE Analysis
5.7. Go-to-Market Strategy for New Market Entrants
5.8. Key Purchase Metrics for End-users
5.9. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
5.10. Benchmarking of the Products Offered by the Leading Competitors
6. Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Therapy Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Therapy Type, 2021-2036
6.3.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
6.3.2. Chloride Channel Activators
6.3.3. Traditional Laxatives
6.3.4. Others
6.4. Market Attractiveness Analysis, by Therapy Type
7. Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Drug Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Drug Type, 2021-2036
7.3.1. Branded Drugs
7.3.2. Generic Drugs
7.4. Market Attractiveness Analysis, by Drug Type
8. Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Prescription Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Prescription Type, 2021-2036
8.3.1. Over-The-Counter
8.3.2. Prescription
8.4. Market Attractiveness Analysis, by Prescription Type
9. Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Route of Administration
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Route of Administration, 2021-2036
9.3.1. Oral
9.3.2. Subcutaneous
9.3.3. Others
9.4. Market Attractiveness Analysis, by Route of Administration
10. Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by Distribution Channel, 2021-2036
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2021-2036
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Opioid Induced Constipation Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Therapy Type, 2021-2036
12.2.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
12.2.2. Chloride Channel Activators
12.2.3. Traditional Laxatives
12.2.4. Others
12.3. Market Value Forecast, by Drug Type, 2021-2036
12.3.1. Branded Drugs
12.3.2. Generic Drugs
12.4. Market Value Forecast, by Prescription Type, 2021-2036
12.4.1. Over-The-Counter
12.4.2. Prescription
12.5. Market Value Forecast, by Route of Administration, 2021-2036
12.5.1. Oral
12.5.2. Subcutaneous
12.5.3. Others
12.6. Market Value Forecast, by Distribution Channel, 2021-2036
12.6.1. Hospital Pharmacies
12.6.2. Retail Pharmacies
12.6.3. Online Pharmacies
12.7. Market Value Forecast, by Country, 2021-2036
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Therapy Type
12.8.2. By Drug Type
12.8.3. By Prescription Type
12.8.4. By Route of Administration
12.8.5. By Distribution Channel
12.8.6. By Country
13. U.S. Opioid Induced Constipation Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Therapy Type, 2021-2036
13.2.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
13.2.2. Chloride Channel Activators
13.2.3. Traditional Laxatives
13.2.4. Others
13.3. Market Value Forecast, by Drug Type, 2021-2036
13.3.1. Branded Drugs
13.3.2. Generic Drugs
13.4. Market Value Forecast, by Prescription Type, 2021-2036
13.4.1. Over-The-Counter
13.4.2. Prescription
13.5. Market Value Forecast, by Route of Administration, 2021-2036
13.5.1. Oral
13.5.2. Subcutaneous
13.5.3. Others
13.6. Market Value Forecast, by Distribution Channel, 2021-2036
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies
13.6.3. Online Pharmacies
13.7. Market Attractiveness Analysis
13.7.1. By Therapy Type
13.7.2. By Drug Type
13.7.3. By Prescription Type
13.7.4. By Route of Administration
13.7.5. By Distribution Channel
14. Canada Opioid Induced Constipation Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Therapy Type, 2021-2036
14.2.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
14.2.2. Chloride Channel Activators
14.2.3. Traditional Laxatives
14.2.4. Others
14.3. Market Value Forecast, by Drug Type, 2021-2036
14.3.1. Branded Drugs
14.3.2. Generic Drugs
14.4. Market Value Forecast, by Prescription Type, 2021-2036
14.4.1. Over-The-Counter
14.4.2. Prescription
14.5. Market Value Forecast, by Route of Administration, 2021-2036
14.5.1. Oral
14.5.2. Subcutaneous
14.5.3. Others
14.6. Market Value Forecast, by Distribution Channel, 2021-2036
14.6.1. Hospital Pharmacies
14.6.2. Retail Pharmacies
14.6.3. Online Pharmacies
14.7. Market Attractiveness Analysis
14.7.1. By Therapy Type
14.7.2. By Drug Type
14.7.3. By Prescription Type
14.7.4. By Route of Administration
14.7.5. By Distribution Channel
15. Europe Opioid Induced Constipation Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Therapy Type, 2021-2036
15.2.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
15.2.2. Chloride Channel Activators
15.2.3. Traditional Laxatives
15.2.4. Others
15.3. Market Value Forecast, by Drug Type, 2021-2036
15.3.1. Branded Drugs
15.3.2. Generic Drugs
15.4. Market Value Forecast, by Prescription Type, 2021-2036
15.4.1. Over-The-Counter
15.4.2. Prescription
15.5. Market Value Forecast, by Route of Administration, 2021-2036
15.5.1. Oral
15.5.2. Subcutaneous
15.5.3. Others
15.6. Market Value Forecast, by Distribution Channel, 2021-2036
15.6.1. Hospital Pharmacies
15.6.2. Retail Pharmacies
15.6.3. Online Pharmacies
15.7. Market Value Forecast, by Country/Sub-region, 2021-2036
15.7.1. Germany
15.7.2. UK
15.7.3. France
15.7.4. Italy
15.7.5. Spain
15.7.6. The Netherlands
15.7.7. Rest of Europe
15.8. Market Attractiveness Analysis
15.8.1. By Therapy Type
15.8.2. By Drug Type
15.8.3. By Prescription Type
15.8.4. By Route of Administration
15.8.5. By Distribution Channel
15.8.6. By Country/Sub-region
16. Germany Opioid Induced Constipation Treatment Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Therapy Type, 2021-2036
16.2.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
16.2.2. Chloride Channel Activators
16.2.3. Traditional Laxatives
16.2.4. Others
16.3. Market Value Forecast, by Drug Type, 2021-2036
16.3.1. Branded Drugs
16.3.2. Generic Drugs
16.4. Market Value Forecast, by Prescription Type, 2021-2036
16.4.1. Over-The-Counter
16.4.2. Prescription
16.5. Market Value Forecast, by Route of Administration, 2021-2036
16.5.1. Oral
16.5.2. Subcutaneous
16.5.3. Others
16.6. Market Value Forecast, by Distribution Channel, 2021-2036
16.6.1. Hospital Pharmacies
16.6.2. Retail Pharmacies
16.6.3. Online Pharmacies
16.7. Market Attractiveness Analysis
16.7.1. By Therapy Type
16.7.2. By Drug Type
16.7.3. By Prescription Type
16.7.4. By Route of Administration
16.7.5. By Distribution Channel
17. UK Opioid Induced Constipation Treatment Market Analysis and Forecast
17.1. Introduction
17.1.1. Key Findings
17.2. Market Value Forecast, by Therapy Type, 2021-2036
17.2.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
17.2.2. Chloride Channel Activators
17.2.3. Traditional Laxatives
17.2.4. Others
17.3. Market Value Forecast, by Drug Type, 2021-2036
17.3.1. Branded Drugs
17.3.2. Generic Drugs
17.4. Market Value Forecast, by Prescription Type, 2021-2036
17.4.1. Over-The-Counter
17.4.2. Prescription
17.5. Market Value Forecast, by Route of Administration, 2021-2036
17.5.1. Oral
17.5.2. Subcutaneous
17.5.3. Others
17.6. Market Value Forecast, by Distribution Channel, 2021-2036
17.6.1. Hospital Pharmacies
17.6.2. Retail Pharmacies
17.6.3. Online Pharmacies
17.7. Market Attractiveness Analysis
17.7.1. By Therapy Type
17.7.2. By Drug Type
17.7.3. By Prescription Type
17.7.4. By Route of Administration
17.7.5. By Distribution Channel
18. France Opioid Induced Constipation Treatment Market Analysis and Forecast
18.1. Introduction
18.1.1. Key Findings
18.2. Market Value Forecast, by Therapy Type, 2021-2036
18.2.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
18.2.2. Chloride Channel Activators
18.2.3. Traditional Laxatives
18.2.4. Others
18.3. Market Value Forecast, by Drug Type, 2021-2036
18.3.1. Branded Drugs
18.3.2. Generic Drugs
18.4. Market Value Forecast, by Prescription Type, 2021-2036
18.4.1. Over-The-Counter
18.4.2. Prescription
18.5. Market Value Forecast, by Route of Administration, 2021-2036
18.5.1. Oral
18.5.2. Subcutaneous
18.5.3. Others
18.6. Market Value Forecast, by Distribution Channel, 2021-2036
18.6.1. Hospital Pharmacies
18.6.2. Retail Pharmacies
18.6.3. Online Pharmacies
18.7. Market Attractiveness Analysis
18.7.1. By Therapy Type
18.7.2. By Drug Type
18.7.3. By Prescription Type
18.7.4. By Route of Administration
18.7.5. By Distribution Channel
19. Italy Opioid Induced Constipation Treatment Market Analysis and Forecast
19.1. Introduction
19.1.1. Key Findings
19.2. Market Value Forecast, by Therapy Type, 2021-2036
19.2.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
19.2.2. Chloride Channel Activators
19.2.3. Traditional Laxatives
19.2.4. Others
19.3. Market Value Forecast, by Drug Type, 2021-2036
19.3.1. Branded Drugs
19.3.2. Generic Drugs
19.4. Market Value Forecast, by Prescription Type, 2021-2036
19.4.1. Over-The-Counter
19.4.2. Prescription
19.5. Market Value Forecast, by Route of Administration, 2021-2036
19.5.1. Oral
19.5.2. Subcutaneous
19.5.3. Others
19.6. Market Value Forecast, by Distribution Channel, 2021-2036
19.6.1. Hospital Pharmacies
19.6.2. Retail Pharmacies
19.6.3. Online Pharmacies
19.7. Market Attractiveness Analysis
19.7.1. By Therapy Type
19.7.2. By Drug Type
19.7.3. By Prescription Type
19.7.4. By Route of Administration
19.7.5. By Distribution Channel
20. Spain Opioid Induced Constipation Treatment Market Analysis and Forecast
20.1. Introduction
20.1.1. Key Findings
20.2. Market Value Forecast, by Therapy Type, 2021-2036
20.2.1. Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
20.2.2. Chloride Channel Activators
20.2.3. Traditional Laxatives
20.2.4. Others
20.3. Market Value Forecast, by Drug Type, 2021-2036
20.3.1. Branded Drugs
20.3.2. Generic Drugs
20.4. Market Value Forecast, by Prescription Type, 2021-2036
20.4.1. Over-The-Counter
20.4.2. Prescription
20.5. Market Value Forecast, by Route of Administration, 2021-2036
20.5.1. Oral
20.5.2. Subcutaneous
20.5.3. Others
20.6. Market Value Forecast, by Distribution Channel, 2021-2036
20.6.1. Hospital Pharmacies
20.6.2. Retail Pharmacies
20.6.3. Online Pharmacies
20.7. Market Attractiveness Analysis
20.7.1. By Therapy Type
20.7.2. By Drug Type
20.7.3. By Prescription Type
20.7.4. By Route of Administration
20.7.5. By Distribution Channel

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us